Overview

• Donald Trump, in a Time magazine interview, stated it is 'highly unlikely' his administration would restrict access to abortion pills mifepristone and misoprostol.
• Trump's comments mark his clearest position yet on ensuring FDA approval for abortion pills remains intact during his presidency.
• Anti-abortion groups, who have advocated for stricter regulations or bans, expressed disappointment but remain focused on reinstating in-person dispensing requirements.
• The Biden administration had expanded access to abortion pills by lifting in-person requirements, allowing online sales and mail delivery of the medication.
• While Trump committed to preserving FDA approval, he hinted at the possibility of revisiting related policies, such as invoking the Comstock Act, which could indirectly limit access.